---
$id: https://graph.org.ai/products/commodity/51262306
$type: Product
source: UNSPSC
code: "51262306"
title: "Fiduxosin hydrochloride"
class: "51262300"
classTitle: "Adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fiduxosin hydrochloride

**UNSPSC Code**: 51262306
**Class**: [Adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines](Adrenergic blocking agent ergolines and heterocyclic compounds, 3-ring and morpholines and pyridazines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic blocking agent C30H29N5O4S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UYV23L1N89, chemically known as pyrazino(2',3':4,5)thieno(3,2-d)pyrimidine-2,4(1h,3h)-dione, 8-phenyl-3-(4-((3ar,9br)-1,3a,4,9b-tetrahydro-9-methoxy(1)benzopyrano(3,4-c)pyrrol-2(3h)-yl)butyl)-, monohydrochloride, but more generally known as fiduxosin hydrochloride, which bears US NIH Compound Identifier 172306. Most nations, for tariff and trade purposes, schedule fiduxosin hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, FIDUXOSIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Fiduxosin hydrochloride bears US NLM identifiers UMLS ID C2825597 and NCI Concept Code C81371. SMILES: COC1CCCC2C1[C@@H]3CN(C[C@@H]3CO2)CCCCN4C(=O)C5C(C6C(S5)NCC(N6)C7CCCCC7)[NH]C4=O.CL.

